Anti-IgE efficacy in murine asthma models is dependent on the method of allergen sensitization

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 6, 2001, Pages 1025-1033

  Tumas, Daniel B ^a   Chan, Betty ^b   Werther, Winifred ^b   Wrin, Terri ^b   Vennari, Joann ^b   Desjardin, Noelyn ^b   Shields, Robert L ^b   Jardieu, Paula ^b  

^a Department of Pathology ^*  (United States)

^b GENENTECH INC   (United States)

Author keywords

Animal disease models; Asthma; Dust mite allergen; IgE; Respiratory syncytial virus

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E ANTIBODY;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG EFFECT; HISTOPATHOLOGY; MEDIATOR RELEASE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT MUCOSA; SENSITIZATION; T LYMPHOCYTE ACTIVATION;

EID: 0035014313     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.115625     Document Type: Article

References (65)

1. Eosinophil inflammation in asthma
2. The pathobiology of bronchial asthma
3. The eosinophilic injury to the mucosa of the airways in the pathogenesis of bronchial asthma
4. The pathology of asthma
5. "Ultimate activation" of eosinophils in vivo: Lysis and release of clusters of free eosinophil granules
6. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway
7. Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma
8. Lung function and immunopathological changes after inhaled corticosteroid therapy in asthma
9. Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage
10. Complexity and redundancy in the pathogenesis of asthma: Reassessing the roles of mast cells and T cells
11. IgE antibody measurements in ragweed hay fever. Relationship to clinical severity and the results of immunotherapy
12. Platts-Mills Epidemiology of acute asthma IgE antibodies to common inhalant allergens as a risk factor for emergency room visits
13. Association of asthma with serum IgE levels and skin-test reactivity to allergens
14. Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies
15. Relation between airway responsiveness and serum IgE in children with asthma and in apparently normal children
16. Clinical significance of IgE
17. The effect of an anti-IgE monoclonal antibody on the early- and late-phase responses to allergen inhalation in asthmatic subjects
18. Therapeutic potential of anti-IgE antibodies
19. Inhibitory effects of an anti-IgE antibody E25 on allergen-induced early asthmatic response
20. Anti-IgE therapy
21. The mouse trap
22. Bronchial asthma: Lessons from murine models
23. Asthma "of mice and men" - How do animal models help us understand human asthma?
24. The relevance of murine animal models to study the development of allergic bronchial asthma
25. Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia
26. Requirement for gammadelta T cells in allergic airway inflammation
27. CTLA4Ig inhibits airway eosinophilia and hyperresponsiveness by regulating the development of Th1/Th2 subsets in a murine model of asthma
28. Murine CTLA4-IgG treatment inhibits airway eosinophilia and hyperresponsiveness and attenuates IgE upregulation in a murine model of allergic asthma
29. Cytokine manipulation in animal models of asthma
30. The coordinated action of C-C chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
31. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors
32. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia
33. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: Inhibition by a non-anaphylactogenic anti-IgE antibody
34. Demonstration of the therapeutic potential of non-anaphylactogenic anti-IgE antibodies in murine models of skin reaction, lung function and inflammation
35. Involvement of intercellular adhesion molecule-1 in antigen-induced infiltration of eosinophils and lymphocytes into the airways in a murine model of pulmonary inflammation
36. Airway recruitment of leukocytes is dependent on alpha-4integrins and vascular cell adhesion molecule-1
37. Reduction of antigen-induced airway hyperreactivity and eosinophilia in ICAM-1-deficient mice
38. Intercellular adhesion molecule-1-deficient mice have antibody responses but impaired leukocyte recruitment
39. Blockade of CD49d (alpha sub 4 integrin) on intrapulmonary but not circulating leukocytes inhibits airway inflammation and hyperresponsiveness in a mouse model of asthma
40. A mite subversive: Cleavage of CD23 and CD25 by Der p 1 enhances allergenicity
41. Viruses as precipitants of asthmatic attacks in children
42. Viral respiratory tract infection and exacerbations of asthma in adult patients
43. Respiratory viruses and exacerbations of asthma in adults
44. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: A prospective cohort study with matched controls
45. Association between pronounced IgA response in RSV bronchiolitis and development of allergic sensitization
46. Respiratory syncytial virus infection results in airway hyperresponsiveness and enhanced airway sensitization to allergen
47. Primary respiratory syncytial virus infection in mice
48. Reinfection of mice with respiratory syncytial virus
49. Administration of anti-IgE antibody inhibits CD 23 expression and IgE production in vivo
50. Subepithelial fibrosis in the bronchi of asthmatics
51. Systemic anaphylaxis in the mouse can be mediated largely through IgG 1 and Fc gammaRIII. Assessment of the cardiopulmonary changes, mast cell degranulation, and death associated with active or IgE- or IgG1-dependent passive anaphylaxis
52. Passive transfer of immediate hypersensitivity and airway hyperresponsiveness by allergen-specific immunoglobulin (1g) E and IgG1 in mice
53. Eosinophils retain their granule major basic protein in a murine model of allergic pulmonary inflammation
54. Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma
55. Tlymphocytes regulate genetically determined airway hyperresponsiveness in mice
56. Characterization of a murine model of allergic pulmonary inflammation
57. Der p 1, a major allergen of the house dust mite, proteolytically cleaves the low-affinity receptor for human IgE (CD23)
58. Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity
59. A major house dust mite allergen disrupts the immunoglobulin E network by selectively cleaving CD23: Innate protection by antiproteases
60. Respiratory syncytial virus infection enhances neutrophil and eosinophil adhesion to cultured respiratory epithelial cells. Roles of CD18 and intercellular adhesion molecule-1
61. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus
62. Vaccines and cytokine-mediated pathology in RSV infection
63. The IgG Fc receptor family
64. Complete structure of mouse mast cell receptor for IgE (Fc epsilon RI and surface expression of chimeric receptors (rat-mouse-human) on transfected cells